JAZZ PHARMACEUTICALS PLC
JAZZ · NASDAQ
Updated at 2026-10-13 14:04:20
- Today's High
- $216.87
- Today’s Low
- $213.53
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $218.90
- Previous Close
- $216.75
- Volume
- 740.49K
- Market Cap
- $14.07B
- P/E Ratio
- 15.11X
- EPS
- $14.62
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- WATERLOO EXCHANGE, DUBLIN, IRELAND, D04 E5W7
- Country
- IE
- Listing Date
- 2012-01-18
- Fiscal Year End
- December
- Shares Outstanding
- 62.82M
- CIK
- 0001232524
- Website
- www.jazzpharma.com
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and markets pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Dublin, Ireland.
Financial Metrics
Revenue
2026-06-30
$1.2B
2026-03-31
$1.06B
2025-12-31
$1.19B
2025-09-30
$1.12B
Operating Expenses
2026-06-30
$843.7M
2026-03-31
$548.7M
2025-12-31
$264.08M
2025-09-30
$810.83M
Net Income
2026-06-30
$192.8M
2026-03-31
$293.1M
2025-12-31
$203.45M
2025-09-30
$251.41M
Net Profit Margin
2026-06-30
15.95%
2026-03-31
27.42%
2025-12-31
16.98%
2025-09-30
22.32%
Earnings Per Share
2026-06-30
$4.89
2026-03-31
$6.34
2025-12-31
$6.64
2025-09-30
$6.99
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$427.2M
2026-03-31
$543.9M
2025-12-31
$432.85M
2025-09-30
$235.85M
Effective Tax Rate
2026-06-30
8.57%
2026-03-31
2.03%
2025-12-31
2.34%
2025-09-30
-2.68K%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $1.2B | $1.06B | $1.19B | $1.12B |
| Operating Expenses | $843.7M | $548.7M | $264.08M | $810.83M |
| Net Income | $192.8M | $293.1M | $203.45M | $251.41M |
| Net Profit Margin | 15.95% | 27.42% | 16.98% | 22.32% |
| Earnings Per Share | $4.89 | $6.34 | $6.64 | $6.99 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $427.2M | $543.9M | $432.85M | $235.85M |
| Effective Tax Rate | 8.57% | 2.03% | 2.34% | -2.68K% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.